Search Results - "Motokawa, S"

Refine Results
  1. 1

    Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin‐6 during treatment for rheumatoid arthritis by Migita, K., Izumi, Y., Jiuchi, Y., Kozuru, H., Kawahara, C., Izumi, M., Sakai, T., Nakamura, M., Motokawa, S., Nakamura, T., Kawakami, A.

    Published in Clinical and experimental immunology (01-02-2014)
    “…Summary The Janus kinase inhibitor tofacitinib is currently being investigated as a disease‐modifying agent in rheumatoid arthritis (RA). We investigated the…”
    Get full text
    Journal Article
  2. 2

    Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds by Migita, K., Izumi, Y., Torigoshi, T., Satomura, K., Izumi, M., Nishino, Y., Jiuchi, Y., Nakamura, M., Kozuru, H., Nonaka, F., Eguchi, K., Kawakami, A., Motokawa, S.

    Published in Clinical and experimental immunology (01-12-2013)
    “…Summary Janus kinase (JAK) inhibitors have been developed as anti‐inflammatory agents and have demonstrated clinical efficacy in rheumatoid arthritis (RA). We…”
    Get full text
    Journal Article
  3. 3

    Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women by Osaki, M., Tatsuki, K., Hashikawa, T., Norimatsu, T., Chiba, K., Motokawa, S., Furuichi, I., Doiguchi, Y., Aoyagi, K., Shindo, H.

    Published in Osteoporosis international (01-02-2012)
    “…Summary A 36-month observational study compared the incidence of unaffected side hip fracture in Japanese female osteoporosis patients with a history of hip…”
    Get full text
    Journal Article
  4. 4

    Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes by Migita, K, Koga, T, Torigoshi, T, Motokawa, S, Maeda, Y, Jiuchi, Y, Izumi, Y, Miyashita, T, Nakamura, M, Komori, A, Ishibashi, H

    Published in Clinical and experimental immunology (01-11-2010)
    “…In this study, we investigated the roles of serum amyloid A (SAA) in T helper 17 (Th17)-related cytokine induction in rheumatoid arthritis (RA) synoviocytes…”
    Get full text
    Journal Article
  5. 5

    Bone mineral densities in patients with developmental dysplasia of the hip by Okano, K, Ito, M, Aoyagi, K, Motokawa, S, Shindo, H

    Published in Osteoporosis international (2011)
    “…Summary Bone mineral density (BMD) of the lumbar spine, ultradistal radius, and calcaneus were significantly higher in the developmental dysplasia of the hip…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes by Migita, Kiyoshi, Koga, Tomohiro, Torigoshi, Takafumi, Maeda, Yumi, Miyashita, Taichiro, Izumi, Yasumori, Aiba, Yoshihiro, Komori, Atsumasa, Nakamura, Minoru, Motokawa, Satoru, Ishibashi, Hiromi

    Published in Rheumatology (Oxford, England) (01-07-2009)
    “…Objective. Although serum amyloid A (SAA) has been used as a marker of inflammation, its role in leucocyte recruitment and angiogenesis has not been well…”
    Get full text
    Journal Article
  8. 8

    Potentiation of glucocorticoid receptor (GR)-mediated signaling by the immunosuppressant tacrolimus in rheumatoid synoviocytes by TORIGOSHI, T, MOTOKAWA, S, ISHIBASHI, H, EGUCHI, K, SHINDO, H, MIGITA, K, MIYASHITA, T, MAEDA, Y, KOGA, T, NAKAMURA, M, KOMORI, A, AIBA, Y, UEMURA, T, YATSUHASHI, H

    Published in Clinical and experimental rheumatology (01-03-2009)
    “…The immunosuppressant tacrolimus is known to enhance many aspects of glucocorticoid. In this study, we investigated the effects of tacrolimus on glucocorticoid…”
    Get full text
    Journal Article
  9. 9
  10. 10

    High prevalence of arthropathy in HTLV-I carriers on a Japanese island by Motokawa, S, Hasunuma, T, Tajima, K, Krieg, A M, Ito, S, Iwasaki, K, Nishioka, K

    Published in Annals of the rheumatic diseases (01-03-1996)
    “…OBJECTIVE: To determine the aetiological relationship between human T cell leukaemia virus type-I (HTLV-I) and arthritis, by performing an epidemiological…”
    Get full text
    Journal Article
  11. 11

    MEMS-based design and fabrication of a new concept micro direct methanol fuel cell (μ-DMFC) by Motokawa, Shinji, Mohamedi, Mohamed, Momma, Toshiyuki, Shoji, Shuichi, Osaka, Tetsuya

    Published in Electrochemistry communications (01-06-2004)
    “…A design for a novel micro direct methanol fuel cell (μ-DMFC) of 0.018 cm 2 active area is described. The μ-DMFC was prepared using a series of fabrication…”
    Get full text
    Journal Article
  12. 12

    Effect of serum factors on skeletal growth in Perthes' disease by Motokawa, S

    Published in Nippon Seikeigekagakkai zasshi (01-09-1990)
    “…It is well known that patients with Perthes' disease have skeletal growth disturbances such as short stature and retardation of bone maturation. The purpose of…”
    Get more information
    Journal Article
  13. 13

    Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes by Koga, Tomohiro, Torigoshi, Takafumi, Motokawa, Satoru, Miyashita, Taichiro, Maeda, Yumi, Nakamura, Minoru, Komori, Atsumasa, Aiba, Yoshihiro, Uemura, Takashi, Yatsuhashi, Hiroshi, Ishibashi, Hiromi, Eguchi, Katsumi, Migita, Kiyoshi

    Published in FEBS letters (05-03-2008)
    “…In this study, we investigated the role of serum amyloid A protein (SAA) in the production of interleukin-6 (IL-6) using rheumatoid arthritis fibroblast-like…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy by Kato, Tomohiro, Asahara, Hiroshi, Kurokawa, Manae Suzuki, Fujisawa, Koushi, Hasunuma, Tomoko, Inoue, Hajime, Tsuda, Masanao, Takahashi, Shigeru, Motokawa, Satoru, Sumida, Takayuki, Nishioka, Kusuki

    Published in Clinical rheumatology (01-10-2004)
    “…Our objective was to investigate the pathological mechanisms of HTLV-I (human T-cell leukemia virus type I)-associated chronic arthritis (HAAP) with respect to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Decreased levels of IGF binding protein-3 in serum from children with Perthes' disease by Matsumoto, T, Enomoto, H, Takahashi, K, Motokawa, S

    Published in Acta orthopaedica Scandinavica (1998)
    “…The concentrations of insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in serum obtained from 27 children with Perthes' disease and 10…”
    Get more information
    Journal Article
  20. 20